Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	109
Overall Study	STARTED	PHEN 7.5 mg	109
Overall Study	STARTED	TPM 46 mg	108
Overall Study	STARTED	VI-0521 Mid	107
Overall Study	STARTED	PHEN 15 mg	108
Overall Study	STARTED	TPM 92 mg	107
Overall Study	STARTED	VI-0521 Top	108
Overall Study	COMPLETED	Placebo	74
Overall Study	COMPLETED	PHEN 7.5 mg	79
Overall Study	COMPLETED	TPM 46 mg	78
Overall Study	COMPLETED	VI-0521 Mid	78
Overall Study	COMPLETED	PHEN 15 mg	80
Overall Study	COMPLETED	TPM 92 mg	77
Overall Study	COMPLETED	VI-0521 Top	75
Overall Study	NOT COMPLETED	Placebo	35
Overall Study	NOT COMPLETED	PHEN 7.5 mg	30
Overall Study	NOT COMPLETED	TPM 46 mg	30
Overall Study	NOT COMPLETED	VI-0521 Mid	29
Overall Study	NOT COMPLETED	PHEN 15 mg	28
Overall Study	NOT COMPLETED	TPM 92 mg	30

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00563368/flow